Literature DB >> 18443366

AP-2alpha and AP-2gamma regulate tumor progression via specific genetic programs.

Francesca Orso1, Elisa Penna, Daniela Cimino, Elena Astanina, Federica Maione, Donatella Valdembri, Enrico Giraudo, Guido Serini, Piero Sismondi, Michele De Bortoli, Daniela Taverna.   

Abstract

The events occurring during tumor formation and progression display similarities to some of the steps in embryonic morphogenesis. The family of AP-2 proteins consists of five different transcription factors (alpha, beta, gamma, delta, and epsilon) that play relevant roles in embryonic development, as demonstrated by the phenotypes of the corresponding knockout mice. Here, we show that AP-2alpha and AP-2gamma proteins play an essential role in tumorigenesis. Down-modulation of AP-2 expression in tumor cells by RNA interference (RNAi) led to enhanced tumor growth and reduced chemotherapy-induced cell death, as well as migration and invasion. Most of these biological modulations were rescued by AP-2 overexpression. We observed that increased xenotransplant growth was mostly due to highly enhanced proliferation of the tumor cells together with reduced innate immune cell recruitment. Moreover, we showed that migration impairment was mediated, at least in part, by secreted factors. To identify the genetic programs involved in tumorigenesis, we performed whole genome microarray analysis of AP-2alpha knockdown cells and observed that AP-2alpha regulates specific genes involved in cell cycle, cell death, adhesion, and migration. In particular, we showed that ESDN, EREG, and CXCL2 play a major role in AP-2 controlled migration, as ablation of any of these genes severely altered migration.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18443366     DOI: 10.1096/fj.08-106492

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  38 in total

1.  Identification of primary gene targets of TFAP2C in hormone responsive breast carcinoma cells.

Authors:  George W Woodfield; Yizhen Chen; Thomas B Bair; Frederick E Domann; Ronald J Weigel
Journal:  Genes Chromosomes Cancer       Date:  2010-10       Impact factor: 5.006

Review 2.  Epiregulin: roles in normal physiology and cancer.

Authors:  David J Riese; Richard L Cullum
Journal:  Semin Cell Dev Biol       Date:  2014-03-12       Impact factor: 7.727

3.  Effects of parathyroid hormone-related protein and macrophage inflammatory protein-1α in Jurkat T-cells on tumor formation in vivo and expression of apoptosis regulatory genes in vitro.

Authors:  Sherry T Shu; Wessel P Dirksen; Lisa G Lanigan; Chelsea K Martin; Nanda K Thudi; Jillian L Werbeck; Soledad A Fernandez; Blake E Hildreth; Thomas J Rosol
Journal:  Leuk Lymphoma       Date:  2012-01-03

4.  Molecular predictors of gemcitabine response in pancreatic cancer.

Authors:  Ioannis A Voutsadakis
Journal:  World J Gastrointest Oncol       Date:  2011-11-15

5.  Inhibition of neural crest formation by Kctd15 involves regulation of transcription factor AP-2.

Authors:  Valeria E Zarelli; Igor B Dawid
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

6.  Identification of functional TFAP2A and SP1 binding sites in new TFAP2A-modulated genes.

Authors:  Francesca Orso; Davide Corà; Benedetta Ubezio; Paolo Provero; Michele Caselle; Daniela Taverna
Journal:  BMC Genomics       Date:  2010-06-03       Impact factor: 3.969

7.  Investigating AP-2 and YY1 protein expression as a cause of high HER2 gene transcription in breast cancers with discordant HER2 gene amplification.

Authors:  Desmond G Powe; Gulfareen Akhtar; Hany Onsy Habashy; Tarek Abdel-Fatah; Emad A Rakha; Andrew R Green; Ian O Ellis
Journal:  Breast Cancer Res       Date:  2009-12-21       Impact factor: 6.466

8.  AP-2alpha induces epigenetic silencing of tumor suppressive genes and microsatellite instability in head and neck squamous cell carcinoma.

Authors:  Kristi L Bennett; Todd Romigh; Charis Eng
Journal:  PLoS One       Date:  2009-09-09       Impact factor: 3.240

9.  AP-2alpha regulates migration of GN-11 neurons via a specific genetic programme involving the Axl receptor tyrosine kinase.

Authors:  Francesca Orso; Richard Jäger; Raffaele Adolfo Calogero; Hubert Schorle; Piero Sismondi; Michele De Bortoli; Daniela Taverna
Journal:  BMC Biol       Date:  2009-05-22       Impact factor: 7.431

10.  Tumour growth and resistance to gemcitabine of pancreatic cancer cells are decreased by AP-2alpha overexpression.

Authors:  N Jonckheere; V Fauquette; L Stechly; N Saint-Laurent; S Aubert; C Susini; G Huet; N Porchet; I Van Seuningen; P Pigny
Journal:  Br J Cancer       Date:  2009-08-18       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.